Scleroderma, Systemic - 20 Studies Found
Completed |
: Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement : Scleroderma, Systemic : 2006-06-02 : Drug: Mycophenolate mofetil |
Completed |
: Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis : Scleroderma, Systemic : 2006-07-03 : Drug: High-dose intravenous immunoglobulin (Venoglobulin-IH) |
Terminated |
: Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis : Scleroderma, Systemic : 2007-01-03 :
|
Recruiting |
: A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis : Scleroderma, Systemic : 2015-10-08 :
|
Completed |
: Imatinib in Systemic Sclerosis : Scleroderma, Systemic : 2007-07-24 : Drug: Imatinib mesylate 100 mg orally daily increased by 100 mg/day every 2 weeks to maximum of 400 mg d |
Not yet recruiting |
: Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis : Scleroderma, Systemic : 2017-01-31 :
|
Recruiting |
: Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis : Scleroderma, Systemic : 2015-12-09 : Other: blood samples one blood sample will be done for dos |
Active, not recruiting |
: Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis : Scleroderma, Systemic : 2014-11-03 :
|
Not yet recruiting |
: The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis : Scleroderma, Systemic : 2015-06-15 : Drug: bosentan 62.5 mg oral twice daily for 4 weeks, then 125 mg oral twice daily. |
Not yet recruiting |
: Platelet Gel in Systemic Sclerosis : Scleroderma, Systemic : 2007-04-19 : Drug: Platelet Gel |